|
Market Closed -
Nasdaq
00:00:00 14/11/2026 +03
|
5-day change | 1st Jan Change | ||
| 39.47 USD | -1.28% |
|
-0.43% | -6.02% |
| 11-11 | Medline's Sales Growth Outlook Remains Intact, Reacceleration Seen in 2028, RBC Says | MT |
| 11-05 | UBS Adjusts Price Target on Medline to $49 From $43, Maintains Buy Rating | MT |
| Market Cap | 34.68B 31.43B 29.07B 26.23B 49.43B 3,270B 51.17B 349B 138B 1,747B 130B 127B 5,545B | P/E 2026 * |
51.5x | P/E 2027 * | 35.6x |
|---|---|---|---|---|---|
| Enterprise Value | 44.72B 40.52B 37.48B 33.82B 63.73B 4,216B 65.97B 450B 179B 2,252B 168B 164B 7,149B | EV / Sales 2026 * |
1.42x | EV / Sales 2027 * | 1.28x |
| Free-Float |
66.63% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| MDLN | Delayed | |
| MDLN | Real-time | ||
| L10 | Real-time | ||
| L10 | Delayed | ||
| L10 | Real-time | ||
| L10 | Delayed |
Last Transcript: Medline Inc.
| 1 day | -1.28% | ||
| 1 week | -0.43% | ||
| Current month | +22.88% | ||
| 1 month | +9.85% | ||
| 3 months | +10.44% | ||
| 6 months | +1.47% | ||
| Current year | -6.02% |
| 1 week | 38.91 | 42.5 | |
| 1 month | 31.37 | 42.5 | |
| Current year | 31.37 | 50.88 | |
| 1 year | 31.37 | 50.88 | |
| 3 years | 31.37 | 50.88 | |
| 5 years | 31.37 | 50.88 | |
| 10 years | 31.37 | 50.88 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/8/26 A | GIC Pte Ltd. (Investment Management)
| Sell | Company | -7,816,987 | 0.8910% | |
| 10/5/26 A | GIC Pte Ltd. (Investment Management)
| Sell | Company | -1,688,690 | 0.1925% | |
| 8/19/26 A | Free | Chief Operating Officer | 87,667 | 0.0119% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.28% | -0.43% | - | - | 34.68B | ||
| +1.18% | -1.28% | -16.90% | +11.78% | 188B | ||
| +1.85% | +1.04% | +7.29% | +41.70% | 126B | ||
| -0.88% | -4.98% | -14.52% | +9.40% | 118B | ||
| +1.36% | -5.91% | -42.82% | +1.32% | 92.48B | ||
| +2.96% | +7.64% | -0.80% | +84.71% | 68.51B | ||
| +1.08% | +2.90% | +12.95% | -6.56% | 59.39B | ||
| +0.89% | +4.17% | +2.07% | +55.03% | 55.48B | ||
| -0.68% | +6.83% | -1.08% | +55.36% | 49.62B | ||
| +1.79% | +0.10% | -0.55% | -8.36% | 35.17B | ||
| Average | +0.83% | +0.53% | -6.04% | +27.15% | 83B | |
| Weighted average by Cap. | +0.94% | -0.38% | -9.05% | +24.76% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 31.4B 28.45B 26.32B 23.75B 44.75B 2,961B 46.33B 316B 125B 1,582B 118B 115B 5,020B | 33.93B 30.75B 28.44B 25.66B 48.36B 3,200B 50.07B 342B 135B 1,709B 127B 125B 5,425B |
| Net income | 960M 870M 804M 726M 1.37B 90.5B 1.42B 9.66B 3.83B 48.34B 3.6B 3.53B 153B | 1.52B 1.38B 1.27B 1.15B 2.17B 143B 2.24B 15.31B 6.07B 76.57B 5.7B 5.58B 243B |
| Net Debt | 10.04B 9.09B 8.41B 7.59B 14.3B 946B 14.81B 101B 40.07B 505B 37.66B 36.86B 1,604B | 8.76B 7.93B 7.34B 6.62B 12.48B 826B 12.92B 88.15B 34.95B 441B 32.86B 32.16B 1,400B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/11/26 | $39.47 | -1.28% | 8,434,226 |
| 12/11/26 | $39.98 | -5.17% | 9,846,992 |
| 11/11/26 | $42.16 | +3.06% | 8,314,152 |
| 10/11/26 | $40.91 | +0.49% | 7,435,848 |
| 09/11/26 | $40.71 | +2.70% | 7,464,613 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- MDLN Stock
Select your edition
All financial news and data tailored to specific country editions
















